Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Irritable Bowel Syndrome, January 2017

Free Subscription


Retrieve all available abstracts of the following 400 articles:
HTML format


Single Articles

  1. HOGESTOL IK, Chahal-Kummen M, Eribe I, Brunborg C, et al
    Chronic Abdominal Pain and Symptoms 5 Years After Gastric Bypass for Morbid Obesity.
    Obes Surg. 2016 Dec 27. doi: 10.1007/s11695-016-2499.
    Abstract     Related articles   

  2. YAZDANI M, Aramesh A, Rafiei R, Daghaghzadeh H, et al
    The comparison of treatments with and without azithromycin in irritable bowel syndrome with diarrhea-predominant in gastrointestinal Clinic of Al-Zahra Hospital, Isfahan, Iran.
    Adv Biomed Res. 2016;5:188.
    Abstract     Related articles   

  3. ROOHAFZA H, Bidaki EZ, Hasanzadeh-Keshteli A, Daghaghzade H, et al
    Anxiety, depression and distress among irritable bowel syndrome and their subtypes: An epidemiological population based study.
    Adv Biomed Res. 2016;5:183.
    Abstract     Related articles   

  4. PISCAGLIA AC, Laterza L, Cesario V, Gerardi V, et al
    Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?
    World J Gastroenterol. 2016;22:10198-10209.
    Abstract     Related articles   

  5. NAVARRO F, Liu Y, Rhoads JM
    Can probiotics benefit children with autism spectrum disorders?
    World J Gastroenterol. 2016;22:10093-10102.
    Abstract     Related articles   

  6. MEARIN F, Ciriza C, Minguez M, Rey E, et al
    [Clinical practice guidelines: Irritable bowel syndrome with constipation and functional constipation in adults: Concept, diagnosis, and healthcare continuity. (Part 1 of 2)].
    Aten Primaria. 2016 Dec 24. pii: S0212-6567(16)30455.
    Abstract     Related articles   

    Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome.
    Neurogastroenterol Motil. 2016 Dec 27. doi: 10.1111/nmo.13007.
    Abstract     Related articles   

  8. GUARINO MP, Cicala M, Putignani L, Severi C, et al
    Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota.
    World J Gastroenterol. 2016;22:9871-9879.
    Abstract     Related articles   

  9. BAUMGARTNER C, Hubacher T, Krayer M, Gschossmann J, et al
    In vitro Spontaneous Contractile Activity of Colonic Smooth Muscle in Naive Lewis Rats: Acute Effect of Gonadal Hormones.
    J Dig Dis. 2016 Dec 23. doi: 10.1111/1751-2980.12438.
    Abstract     Related articles   

    A review of dose-responses of probiotics in human studies.
    Benef Microbes. 2016 Dec 23:1-10. doi: 10.3920/BM2016.0140.
    Abstract     Related articles   

  11. REED DE, Vanner SJ
    Emerging Studies of Human Visceral Nociceptors.
    Am J Physiol Gastrointest Liver Physiol. 2016 Dec 22:ajpgi.00391.2016.
    Abstract     Related articles   

  12. CAMARA-LEMARROY CR, Diaz-Torres MA
    Reply to "Prevalence and impact of irritable bowel syndrome in people with epilepsy: Methodological issues".
    Epilepsy Behav. 2016 Dec 19. pii: S1525-5050(16)30706.
    Abstract     Related articles   

  13. KICH DM, Vincenzi A, Majolo F, Volken de Souza CF, et al
    Probiotic: effectiveness nutrition in cancer treatment and prevention.
    Nutr Hosp. 2016;33:1430-1437.
    Abstract     Related articles   

  14. FANG X
    [Application of Roman IIII( criteria in the diagnosis of chronic constipation].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2016;19:1321-1323.
    Abstract     Related articles   

  15. QI R, Liu C, Weng Y, Xu Q, et al
    Disturbed Interhemispheric Functional Connectivity Rather than Structural Connectivity in Irritable Bowel Syndrome.
    Front Mol Neurosci. 2016;9:141.
    Abstract     Related articles   

  16. LANGLOIS LD, Le Long E, Meleine M, Antor M, et al
    Acute sacral nerve stimulation reduces visceral mechanosensitivity in a cross-organ sensitization model.
    Neurogastroenterol Motil. 2016 Nov 7. doi: 10.1111/nmo.12987.
    Abstract     Related articles   

  17. ALBUSODA A, Barki N, Herregods T, Kamphuis JB, et al
    A fresh look at IBS-opportunities for systems medicine approaches.
    Neurogastroenterol Motil. 2016 Nov 7. doi: 10.1111/nmo.12989.
    Abstract     Related articles   

  18. FARRE R, Vicario M
    Abnormal Barrier Function in Gastrointestinal Disorders.
    Handb Exp Pharmacol. 2016.
    Abstract     Related articles   

  19. CAMILLERI M, Ford AC
    Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.
    Handb Exp Pharmacol. 2016.
    Abstract     Related articles   

  20. DOS SANTOS SJ, Whiteley MS
    Pelvic congestion syndrome masquerading as osteoarthritis of the hip.
    SAGE Open Med Case Rep. 2016;4:2050313X16683630.
    Abstract     Related articles   

  21. REBER SO, Slattery DA
    Editorial: Using Stress-Based Animal Models to Understand the Mechanisms Underlying Psychiatric and Somatic Disorders.
    Front Psychiatry. 2016;7:192.
    Abstract     Related articles   

  22. MICHALAK A, Mosinska P, Fichna J
    Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer.
    Front Pharmacol. 2016;7:459.
    Abstract     Related articles   

  23. CAO DY, Bai G, Ji Y, Karpowicz JM, et al
    EXPRESS: Histone hyperacetylation modulates spinal type II metabotropic glutamate receptor alleviating stress-induced visceral hypersensitivity in female rats.
    Mol Pain. 2016;12.
    Abstract     Related articles   

  24. ASANO T, Tanaka KI, Tada A, Shimamura H, et al
    Aminophylline suppresses stress-induced visceral hypersensitivity and defecation in irritable bowel syndrome.
    Sci Rep. 2017;7:40214.
    Abstract     Related articles   

  25. ABEY SK, Yuana Y, Joseph PV, Kenea ND, et al
    Lysozyme association with circulating RNA, extracellular vesicles, and chronic stress.
    BBA Clin. 2016;7:23-35.
    Abstract     Related articles   

  26. DOMZAL-MAGROWSKA D, Kowalski MK, Szczesniak P, Bulska M, et al
    The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes.
    Prz Gastroenterol. 2016;11:276-281.
    Abstract     Related articles   

  27. PERVEEN I, Parvin R, Saha M, Bari MS, et al
    Prevalence of Irritable Bowel Syndrome (IBS), Migraine and Co-Existing IBS-Migraine in Medical Students.
    J Clin Diagn Res. 2016;10:OC09-OC13.
    Abstract     Related articles   

  28. RIZZI A, Nucera E, Laterza L, Gaetani E, et al
    Irritable Bowel Syndrome and Nickel Allergy: What Is the Role of the Low Nickel Diet?
    J Neurogastroenterol Motil. 2017;23:101-108.
    Abstract     Related articles   

  29. LEE HJ, Choi JK, Ryu HS, Choi CH, et al
    Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders.
    J Neurogastroenterol Motil. 2017;23:9-19.
    Abstract     Related articles   

  30. RODRIGUEZ-FANDINO OA, Hernandez-Ruiz J, Lopez-Vidal Y, Charua-Guindic L, et al
    Maturation Phenotype of Peripheral Blood Monocyte/Macrophage After Stimulation with Lipopolysaccharides in Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2017 Jan 2. doi: 10.5056/jnm16137.
    Abstract     Related articles   

  31. BAI T, Li Y, Xia J, Jiang Y, et al
    Piezo2: A Candidate Biomarker for Visceral Hypersensitivity in Irritable Bowel Syndrome?
    J Neurogastroenterol Motil. 2017 Jan 2. doi: 10.5056/jnm16114.
    Abstract     Related articles   

  32. CANON M, Ruiz AJ, Rondon M, Alvarado J, et al
    Prevalence of irritable bowel syndrome and health-related quality of life in adults aged 18 to 30 years in a Colombian University: an electronic survey.
    Ann Gastroenterol. 2017;30:67-75.
    Abstract     Related articles   

  33. TSIAKIRIS G, Neely G, Lind N, Nordin S, et al
    Comorbidity in allergic asthma and allergic rhinitis: functional somatic syndromes.
    Psychol Health Med. 2016 Dec 30:1-6. doi: 10.1080/13548506.2016.1276606.
    Abstract     Related articles   

  34. VIDEHULT FK, West CE
    Nutrition, gut microbiota and child health outcomes.
    Curr Opin Clin Nutr Metab Care. 2016;19:208-13.
    Abstract     Related articles   

  35. BECKERS AB, Keszthelyi D, Fikree A, Vork L, et al
    Gastrointestinal disorders in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type: a review for the gastroenterologist.
    Neurogastroenterol Motil. 2017 Jan 13. doi: 10.1111/nmo.13013.
    Abstract     Related articles   

  36. SHABANZADEH DM, Sorensen LT, Jorgensen T
    Which Abdominal Symptoms are Associated with Clinical Events in a Population Unaware of Their Gallstones? a Cohort Study.
    J Gastrointest Surg. 2017 Jan 12. doi: 10.1007/s11605-016-3349.
    Abstract     Related articles   

  37. REY E, Mearin F, Alcedo J, Ciriza C, et al
    Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report.
    Adv Ther. 2017 Jan 12. doi: 10.1007/s12325-016-0473.
    Abstract     Related articles   

  38. LYRA A, Hillila M, Huttunen T, Mannikko S, et al
    Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
    World J Gastroenterol. 2016;22:10631-10642.
    Abstract     Related articles   

  39. YANG C, Xiong Y, Zhang SS, An FM, et al
    Regulating effect of TongXie-YaoFang on colonic epithelial secretion via Cl- and HCO3- channel.
    World J Gastroenterol. 2016;22:10584-10591.
    Abstract     Related articles   

  40. QIN X
    Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001010.
    Abstract     Related articles   

  41. CREMON C, Bellacosa L, Barbaro MR, Cogliandro RF, et al
    The diagnostic challenge of symptomatic uncomplicated diverticular disease.
    Minerva Gastroenterol Dietol. 2017 Jan 12. doi: 10.23736/S1121-421X.17.02370.
    Abstract     Related articles   

  42. AJDACIC-GROSS V, Aleksandrowicz A, Rodgers S, Mutsch M, et al
    Infectious, atopic and inflammatory diseases, childhood adversities and familial aggregation are independently associated with the risk for mental disorders: Results from a large Swiss epidemiological study.
    World J Psychiatry. 2016;6:419-430.
    Abstract     Related articles   

  43. CHEN MX, Chen Y, Fu R, Liu SY, et al
    Activation of 5-HT and NR2B contributes to visceral hypersensitivity in irritable bowel syndrome in rats.
    Am J Transl Res. 2016;8:5580-5590.
    Abstract     Related articles   

  44. SHEEN PA, Zahid MS, Fagbemi A, Fullwood C, et al
    'Holiday sickness'-reported exploratory outcome of over 500 United Kingdom holidaymakers with travellers' diarrhoea.
    J Travel Med. 2017;24.
    Abstract     Related articles   

    Advances in IBS 2016: A Review of Current and Emerging Data.
    Gastroenterol Hepatol (N Y). 2016;12.
    Abstract     Related articles   

  46. GERVASONI J, Schiattarella A, Giorgio V, Primiano A, et al
    Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome.
    Dis Markers. 2016;2016:5340386.
    Abstract     Related articles   

  47. ROMIJN AR, Rucklidge JJ, Kuijer RG, Frampton C, et al
    A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression.
    Aust N Z J Psychiatry. 2017 Jan 1:4867416686694. doi: 10.1177/0004867416686694.
    Abstract     Related articles   

  48. DAHL WJ, Agro NC, Eliasson AM, Mialki KL, et al
    Health Benefits of Fiber Fermentation.
    J Am Coll Nutr. 2017 Jan 9:1-10. doi: 10.1080/07315724.2016.1188737.
    Abstract     Related articles   

  49. BOUCHOUCHA M, Devroede G, Bon C, Bejou B, et al
    Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
    Tech Coloproctol. 2017 Jan 9. doi: 10.1007/s10151-016-1580.
    Abstract     Related articles   

  50. PELLISSIER S, Bonaz B
    The Place of Stress and Emotions in the Irritable Bowel Syndrome.
    Vitam Horm. 2017;103:327-354.
    Abstract     Related articles   

  51. FOURIE NH, Wang D, Abey SK, Creekmore AL, et al
    Structural and functional alterations in the colonic microbiome of the rat in a model of stress induced irritable bowel syndrome.
    Gut Microbes. 2017 Jan 6:0. doi: 10.1080/19490976.2016.1273999.
    Abstract     Related articles   

  52. AL-BAWARDY B, Sheedy SP, Herberts MB, Murray JA, et al
    Collagenous sprue cross-sectional imaging: a comparative blinded study.
    Abdom Radiol (NY). 2017 Jan 5. doi: 10.1007/s00261-016-1007.
    Abstract     Related articles   

  53. ZHANG F, Xiang W, Li CY, Li SC, et al
    Economic burden of irritable bowel syndrome in China.
    World J Gastroenterol. 2016;22:10450-10460.
    Abstract     Related articles   

  54. CEULEERS H, Van Spaendonk H, Hanning N, Heirbaut J, et al
    Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases.
    World J Gastroenterol. 2016;22:10275-10286.
    Abstract     Related articles   

  55. FIROUZYAR T, Jalilian AR, Aboudzadeh MR, Sadeghpour H, et al
    Development of a radiolabeled amlodipine analog for L-type calcium channel imaging.
    Curr Radiopharm. 2017.
    Abstract     Related articles   

  56. EHMAN EC, Phelps AS, Ohliger MA, Rhee SJ, et al
    Detection of bowel inflammation with fused DWI/T2 images versus contrast-enhanced images in pediatric MR enterography with histopathologic correlation.
    Clin Imaging. 2016;40:1135-1139.
    Abstract     Related articles   

  57. BALLOU S, Keefer L
    Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases.
    Clin Transl Gastroenterol. 2017;8:e214.
    Abstract     Related articles   

  58. BRON PA, Kleerebezem M, Brummer RJ, Cani PD, et al
    Can probiotics modulate human disease by impacting intestinal barrier function?
    Br J Nutr. 2017 Jan 19:1-15. doi: 10.1017/S0007114516004037.
    Abstract     Related articles   

  59. ANDERSSON H, Tullberg C, Ahrne S, Hamberg K, et al
    Oral Administration of Lactobacillus plantarum 299v Reduces Cortisol Levels in Human Saliva during Examination Induced Stress: A Randomized, Double-Blind Controlled Trial.
    Int J Microbiol. 2016;2016:8469018.
    Abstract     Related articles   

  60. EDMAN JS, Greeson JM, Roberts RS, Kaufman AB, et al
    Perceived stress in patients with common gastrointestinal disorders: Associations with quality of life, symptoms, and disease management.
    Explore (NY). 2016 Dec 16. pii: S1550-8307(16)30234.
    Abstract     Related articles   

  61. KOPPEN IJ, Nurko S, Saps M, Di Lorenzo C, et al
    The pediatric Rome IV criteria: what's new?
    Expert Rev Gastroenterol Hepatol. 2017.
    Abstract     Related articles   

  62. ABDALLA MI, Sandler RS, Kappelman MD, Martin CF, et al
    Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001017.
    Abstract     Related articles   

  63. VISSIENNON C, Goos KH, Arnhold J, Nieber K, et al
    Mechanisms on spasmolytic and anti-inflammatory effects of a herbal medicinal product consisting of myrrh, chamomile flower, and coffee charcoal.
    Wien Med Wochenschr. 2017 Jan 13. doi: 10.1007/s10354-016-0538.
    Abstract     Related articles   

  64. SHKLYAEV AE, Pantyukhina AS, Gorbunov YV
    [The multifunctional therapy of various forms of irritable bowel syndrome].
    Vopr Kurortol Fizioter Lech Fiz Kult. 2016;93:37-40.
    Abstract     Related articles   

  65. BELLINI M, Usai-Satta P, Bove A, Bocchini R, et al
    Chronic constipation diagnosis and treatment evaluation: the "CHRO.CO.DI.T.E." study.
    BMC Gastroenterol. 2017;17:11.
    Abstract     Related articles   

  66. KHADEMVATAN S, Masjedizadeh R, Rahim F, Mahbodfar H, et al
    Blastocystis and irritable bowel syndrome: Frequency and subtypes from Iranian patients.
    Parasitol Int. 2017;66:142-145.
    Abstract     Related articles   

  67. JONES MP, Tack J, Van Oudenhove L, Walker MM, et al
    Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but not in the Population.
    Clin Gastroenterol Hepatol. 2017 Jan 10. pii: S1542-3565(17)30013.
    Abstract     Related articles   

  68. CAMILLERI M, Halawi H, Oduyebo I
    Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?
    Expert Rev Gastroenterol Hepatol. 2017.
    Abstract     Related articles   

  69. CAYZEELE-DECHERF A, Pelerin F, Leuillet S, Douillard B, et al
    Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis.
    World J Gastroenterol. 2017;23:336-344.
    Abstract     Related articles   

  70. ZAMUDIO-TIBURCIO A, Bermudez-Ruiz H, Lezama-Guzman HR, Guevara-Ortigoza MD, et al
    [Breaking paradigms. Intestinal microbiota transplantation: Preliminar report].
    Cir Cir. 2017 Jan 23. pii: S0009-7411(16)30145.
    Abstract     Related articles   

  71. NAITOU K, Shiina T, Nakamori H, Sano Y, et al
    Colokinetic effect of somatostatin in the spinal defecation center in rats.
    J Physiol Sci. 2017 Jan 25. doi: 10.1007/s12576-017-0524.
    Abstract     Related articles   

  72. BANNAGA A, Kelman L, O'Connor M, Pitchford C, et al
    How bad is bile acid diarrhoea: an online survey of patient-reported symptoms and outcomes.
    BMJ Open Gastroenterol. 2017;4:e000116.
    Abstract     Related articles   

  73. QIN Z, Li B, Wu J, Tian J, et al
    Acupuncture for chronic diarrhea in adults: Protocol for a systematic review.
    Medicine (Baltimore). 2017;96:e5952.
    Abstract     Related articles   

  74. CABRERA-CHAVEZ F, Dezar GV, Islas-Zamorano AP, Espinoza-Alderete JG, et al
    Prevalence of Self-Reported Gluten Sensitivity and Adherence to a Gluten-Free Diet in Argentinian Adult Population.
    Nutrients. 2017;9.
    Abstract     Related articles   

  75. LEE KN, Lee OY
    The Role of Mast Cells in Irritable Bowel Syndrome.
    Gastroenterol Res Pract. 2016;2016:2031480.
    Abstract     Related articles   

  76. WILLIAMS TE, Chalder T, Sharpe M, White PD, et al
    Heterogeneity in chronic fatigue syndrome - empirically defined subgroups from the PACE trial.
    Psychol Med. 2017 Jan 23:1-12. doi: 10.1017/S0033291716003615.
    Abstract     Related articles   

  77. PORTINCASA P, Bonfrate L, de Bari O, Lembo A, et al
    Irritable bowel syndrome and diet.
    Gastroenterol Rep (Oxf). 2017 Jan 20. pii: gow047. doi: 10.1093.
    Abstract     Related articles   

  78. PRAMANICK P, Chakraborty A, Raychaudhuri SS
    Phenotypic and biochemical alterations in relation to MT2 gene expression in Plantago ovata Forsk under zinc stress.
    Biometals. 2017 Jan 20. doi: 10.1007/s10534-017-9990.
    Abstract     Related articles   

  79. LI N, Tian H, Ma C, Ding C, et al
    [Efficacy analysis of fecal microbiota transplantation in the treatment of 406 cases with gastrointestinal disorders].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20:40-46.
    Abstract     Related articles   

  80. GALLOTTA S, Bruno V, Catapano S, Mobilio N, et al
    High risk of temporomandibular disorder in irritable bowel syndrome: Is there a correlation with greater illness severity?
    World J Gastroenterol. 2017;23:103-109.
    Abstract     Related articles   

  81. REN HX, Zhang FC, Luo HS, Zhang G, et al
    Role of mast cell-miR-490-5p in irritable bowel syndrome.
    World J Gastroenterol. 2017;23:93-102.
    Abstract     Related articles   

  82. VALDOVINOS MA, Montijo E, Abreu AT, Heller S, et al
    The Mexican consensus on probiotics in gastroenterology.
    Rev Gastroenterol Mex. 2017 Jan 16. pii: S0375-0906(16)30093.
    Abstract     Related articles   

  83. ROKANA N, Singh R, Mallappa RH, Batish VK, et al
    Modulation of intestinal barrier function to ameliorate Salmonella infection in mice by oral administration of fermented milks produced with Lactobacillus plantarum MTCC 5690 - a probiotic strain of Indian gut origin.
    J Med Microbiol. 2016;65:1482-1493.
    Abstract     Related articles   

  84. BLASZKOWSKA J, Goralska K
    Clinical cases of parasitoses and fungal infections important from medical point of view
    Ann Parasitol. 2016;62:255-265.
    Abstract     Related articles   

  85. TAMANAI-SHACOORI Z, Smida I, Bousarghin L, Loreal O, et al
    Roseburia spp.: a marker of health?
    Future Microbiol. 2017;12:157-170.
    Abstract     Related articles   

  86. OSWIECIMSKA J, Szymlak A, Roczniak W, Girczys-Poledniok K, et al
    New insights into the pathogenesis and treatment of irritable bowel syndrome.
    Adv Med Sci. 2017;62:17-30.
    Abstract     Related articles   

  87. PEARSON JS, Whorwell PJ
    Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.
    Curr Opin Gastroenterol. 2017;33:21-25.
    Abstract     Related articles   

  88. MALIKOWSKI T, Khanna S, Pardi DS
    Fecal microbiota transplantation for gastrointestinal disorders.
    Curr Opin Gastroenterol. 2017;33:8-13.
    Abstract     Related articles   

  89. ROMANA B, Tahan V
    Rifaximin in treatment of patients with Irritable bowel syndrome.
    Turk J Gastroenterol. 2017;28:77-78.
    Abstract     Related articles   

  90. GOK EG, Inci A, Coban M, Kutsal DA, et al
    Functional bowel disorders and associated risk factors in hemodialysis patients in Turkey.
    Turk J Gastroenterol. 2017;28:12-19.
    Abstract     Related articles   

    Improving clinical care for patients with irritable bowel syndrome.
    Br J Nurs. 2017;26:76-80.
    Abstract     Related articles   

  92. RIM TH, Kang MJ, Choi M, Seo KY, et al
    Ten-year incidence and prevalence of clinically diagnosed blepharitis in South Korea: A nationwide population-based cohort study.
    Clin Exp Ophthalmol. 2017 Feb 9. doi: 10.1111/ceo.12929.
    Abstract     Related articles   

  93. LIU HN, Wu H, Chen YZ, Chen YJ, et al
    Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis.
    Dig Liver Dis. 2017 Jan 21. pii: S1590-8658(17)30146.
    Abstract     Related articles   

  94. GREENWOOD-VAN MEERVELD B, Johnson AC, Grundy D
    Gastrointestinal Physiology and Function.
    Handb Exp Pharmacol. 2017 Feb 8. doi: 10.1007/164_2016.
    Abstract     Related articles   

  95. JOHNSON AC, Greenwood-Van Meerveld B
    Critical Evaluation of Animal Models of Gastrointestinal Disorders.
    Handb Exp Pharmacol. 2017 Feb 8. doi: 10.1007/164_2016.
    Abstract     Related articles   

  96. CHANG L, Heitkemper MM, Wiley JW, Camilleri M, et al
    2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome.
    Cell Mol Gastroenterol Hepatol. 2016;2:394-399.
    Abstract     Related articles   

  97. MANSOURI A, Amini Rarani M, Fallahi M, Alvandi I, et al
    Irritable Bowel Syndrome is concentrated in people with higher educations in Iran: an inequality analysis.
    Epidemiol Health. 2017 Feb 1. doi: 10.4178/epih.e2017005.
    Abstract     Related articles   

  98. CULVER HR, Clegg JR, Peppas NA
    Analyte-Responsive Hydrogels: Intelligent Materials for Biosensing and Drug Delivery.
    Acc Chem Res. 2017 Feb 7. doi: 10.1021/acs.accounts.6b00533.
    Abstract     Related articles   

  99. FANT RV, Henningfield JE, Cash BD, Dove LS, et al
    Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea.
    Clin Gastroenterol Hepatol. 2017 Feb 3. pii: S1542-3565(17)30134.
    Abstract     Related articles   

  100. YUAN F, Ni H, Asche CV, Kim M, et al
    Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
    Curr Med Res Opin. 2017 Feb 6:1-17. doi: 10.1080/03007995.2017.1292230.
    Abstract     Related articles   

  101. PADHY SK, Mishra S, Sarkar S, Bang LG, et al
    Comparison of psychiatric morbidity in patients with irritable bowel syndrome and non-ulcer dyspepsia.
    Ind Psychiatry J. 2016;25:29-34.
    Abstract     Related articles   

  102. ZENG ZX, Wang H, Yang X
    [Advances in treatment of irritable bowel syndrome].
    Zhonghua Nei Ke Za Zhi. 2017;56:140-143.
    Abstract     Related articles   

  103. D'ALCAMO A, Mansueto P, Soresi M, Iacobucci R, et al
    Contact Dermatitis Due to Nickel Allergy in Patients Suffering from Non-Celiac Wheat Sensitivity.
    Nutrients. 2017;9.
    Abstract     Related articles   

  104. MISHIMA T, Fukae J, Fujioka S, Inoue K, et al
    The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria.
    J Parkinsons Dis. 2017 Jan 30. doi: 10.3233/JPD-160982.
    Abstract     Related articles   

  105. FUKUDO S, Matsueda K, Haruma K, Ida M, et al
    Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo-controlled phase II study.
    Neurogastroenterol Motil. 2017 Feb 16. doi: 10.1111/nmo.13023.
    Abstract     Related articles   

  106. LUCAK S, Chang L, Halpert A, Harris LA, et al
    Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice.
    Therap Adv Gastroenterol. 2017;10:253-275.
    Abstract     Related articles   

  107. BUONO JL, Carson RT, Flores NM
    Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
    Health Qual Life Outcomes. 2017;15:35.
    Abstract     Related articles   

  108. GULERIA A, Karyampudi A, Singh R, Khetrapal CL, et al
    Mapping of Brain Activations to Rectal Balloon Distension Stimuli in Male Patients with Irritable Bowel Syndrome Using Functional Magnetic Resonance Imaging.
    J Neurogastroenterol Motil. 2017 Feb 14. doi: 10.5056/jnm16148.
    Abstract     Related articles   

  109. ZIELINSKA M, Fichna J, Bashashati M, Habibi S, et al
    G protein-coupled estrogen receptor and estrogen receptor ligands regulate colonic motility and visceral pain.
    Neurogastroenterol Motil. 2017 Feb 12. doi: 10.1111/nmo.13025.
    Abstract     Related articles   

  110. GUPTA A, Cole S, Labus JS, Joshi S, et al
    Gene expression profiles in peripheral blood mononuclear cells correlate with salience network activity in chronic visceral pain: A pilot study.
    Neurogastroenterol Motil. 2017 Feb 12. doi: 10.1111/nmo.13027.
    Abstract     Related articles   

  111. JEMBREK MJ, Auteri M, Serio R, Vlainic J, et al
    GABAergic system in action: connection to gastrointestinal stress-related disorders.
    Curr Pharm Des. 2017 Feb 9. doi: 10.2174/1381612823666170209155753.
    Abstract     Related articles   

  112. MEARIN F, Ciriza C, Minguez M, Rey E, et al
    [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)].
    Semergen. 2017 Feb 8. pii: S1138-3593(17)30009.
    Abstract     Related articles   

  113. ZIELINSKA M, Jarmuz A, Wasilewski A, Cami-Kobeci G, et al
    Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.
    Pharmacol Rep. 2016;69:350-357.
    Abstract     Related articles   

  114. FIKREE A, Chelimsky G, Collins H, Kovacic K, et al
    Gastrointestinal involvement in the Ehlers-Danlos syndromes.
    Am J Med Genet C Semin Med Genet. 2017 Feb 10. doi: 10.1002/ajmg.c.31546.
    Abstract     Related articles   

    Review of the role of probiotics in gastrointestinal diseases in adults.
    Gastroenterol Hepatol. 2017 Feb 6. pii: S0210-5705(17)30003.
    Abstract     Related articles   

  116. SHARMA A, Rao S
    Constipation: Pathophysiology and Current Therapeutic Approaches.
    Handb Exp Pharmacol. 2017 Feb 10. doi: 10.1007/164_2016.
    Abstract     Related articles   

  117. BROCHARD C, Venara A, Bodere A, Ropert A, et al
    Pathophysiology of fecal incontinence in obese patients: A prospective case-matched study of 201 patients.
    Neurogastroenterol Motil. 2017 Feb 23. doi: 10.1111/nmo.13051.
    Abstract     Related articles   

  118. KOTZE LM, Costa CT, Cavassani MF, Nisihara RM, et al
    Alert for bone alterations and low serum concentrations of vitamin D in patients with intestinal inflammatory disease.
    Rev Assoc Med Bras (1992). 2017;63:13-17.
    Abstract     Related articles   

    Irritable bowel syndrome in adults: symptoms, treatment and management.
    Nurs Stand. 2017;31:52-63.
    Abstract     Related articles   

  120. RUSSO R, Cristiano C, Avagliano C, De Caro C, et al
    Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases.
    Curr Med Chem. 2017 Feb 16. doi: 10.2174/0929867324666170216113756.
    Abstract     Related articles   

  121. RAMAN M
    Testing for Chronic Diarrhea.
    Adv Clin Chem. 2017;79:199-244.
    Abstract     Related articles   

  122. EDEBOL-CARLMAN H, Ljotsson B, Linton SJ, Boersma K, et al
    Face-to-Face Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: The Effects on Gastrointestinal and Psychiatric Symptoms.
    Gastroenterol Res Pract. 2017;2017:8915872.
    Abstract     Related articles   

  123. MANOLAKIS AC, Christodoulidis G, Kapsoritakis AN, Georgoulias P, et al
    alpha2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease.
    World J Gastroenterol. 2017;23:437-446.
    Abstract     Related articles   

  124. HAN CJ, Kohen R, Jun S, Jarrett ME, et al
    COMT Val158Met Polymorphism and Symptom Improvement Following a Cognitively Focused Intervention for Irritable Bowel Syndrome.
    Nurs Res. 2017;66:75-84.
    Abstract     Related articles   

  125. DE PALMA G, Lynch MD, Lu J, Dang VT, et al
    Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.
    Sci Transl Med. 2017;9.
    Abstract     Related articles   

  126. LOWE C, Aiken A, Day AG, Depew W, et al
    Sham acupuncture is as efficacious as true acupuncture for the treatment of IBS: A randomized placebo controlled trial.
    Neurogastroenterol Motil. 2017 Mar 2. doi: 10.1111/nmo.13040.
    Abstract     Related articles   

  127. SUGAWARA N, Sato K, Takahashi I, Satake R, et al
    Depressive Symptoms and Coping Behaviors among Individuals with Irritable Bowel Syndrome in Japan.
    Intern Med. 2017;56:493-498.
    Abstract     Related articles   

  128. DLUGOSZ A, Zakikhany K, Acevedo N, D'Amato M, et al
    Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome.
    Biomed Res Int. 2017;2017:9624702.
    Abstract     Related articles   

  129. CLAVE P, Tack J
    Efficacy of otilonium bromide in irritable bowel syndrome: a pooled analysis.
    Therap Adv Gastroenterol. 2017;10:311-322.
    Abstract     Related articles   

  130. MOSER G, Peter J
    [Brain-gut axis and gut-directed hypnosis - success of an integrated psychosomatic treatment in gastroenterology].
    Z Psychosom Med Psychother. 2017;63:5-19.
    Abstract     Related articles   

  131. ASHRAFI-ASGARABAD A, Ayubi E, Safiri S
    Prevalence and impact of irritable bowel syndrome in people with epilepsy: Methodological issues.
    Epilepsy Behav. 2017 Feb 24. pii: S1525-5050(16)30648.
    Abstract     Related articles   

  132. MULUGETA M, Tache Y, Larauche M, Yuan PQ, et al
    Brain and gut CRF signaling: biological actions and role in the gastrointestinal tract.
    Curr Mol Pharmacol. 2017 Feb 23. doi: 10.2174/1874467210666170224095741.
    Abstract     Related articles   

  133. SANCHEZ CUEN JA, Irineo Cabrales AB, Bernal Magana G, Peraza Garay FJ, et al
    Health-related quality of life in adults with irritable bowel syndrome in a Mexican specialist hospital. A cross-sectional study.
    Rev Esp Enferm Dig. 2017;109.
    Abstract     Related articles   

  134. MEARIN F, Ciriza C, Minguez M, Rey E, et al
    [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)].
    Aten Primaria. 2017 Feb 23. pii: S0212-6567(17)30131.
    Abstract     Related articles   

  135. YI L, Zhang H, Sun H, Zhou L, et al
    Maternal Separation Induced Visceral Hypersensitivity from Childhood to Adulthood.
    J Neurogastroenterol Motil. 2017 Feb 25. doi: 10.5056/jnm16089.
    Abstract     Related articles   

  136. BEATTY JK, Akierman SV, Motta JP, Muise S, et al
    Giardia duodenalis induces dysbiosis of human intestinal microbiota biofilms.
    Int J Parasitol. 2017 Feb 22. pii: S0020-7519(17)30040.
    Abstract     Related articles   

  137. KUMAR S, Shukla R, Ranjan P, Kumar A, et al
    Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome.
    Clin Ther. 2017 Feb 23. pii: S0149-2918(17)30076.
    Abstract     Related articles   

  138. SAPS M, Miranda A
    Gastrointestinal Pharmacology.
    Handb Exp Pharmacol. 2017 Feb 25. doi: 10.1007/164_2016.
    Abstract     Related articles   

  139. O'MAHONY SM, Clarke G, Dinan TG, Cryan JF, et al
    Irritable Bowel Syndrome and Stress-Related Psychiatric Co-morbidities: Focus on Early Life Stress.
    Handb Exp Pharmacol. 2017 Feb 24. doi: 10.1007/164_2016.
    Abstract     Related articles   

  140. PRUSATOR DK, Chang L
    Sex-Related Differences in GI Disorders.
    Handb Exp Pharmacol. 2017 Feb 24. doi: 10.1007/164_2016.
    Abstract     Related articles   

  141. KHAN I, Samson SE, Grover AK
    Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.
    Med Princ Pract. 2017 Mar 8. doi: 10.1159/000468988.
    Abstract     Related articles   

  142. CHEN JD, Yin J, Wei W
    Electrical therapies for gastrointestinal motility disorders.
    Expert Rev Gastroenterol Hepatol. 2017 Mar 6. doi: 10.1080/17474124.2017.1298441
    Abstract     Related articles   

  143. WHITEHEAD WE, Palsson OS, Simren M
    Irritable bowel syndrome: what do the new Rome IV diagnostic guidelines mean for patient management?
    Expert Rev Gastroenterol Hepatol. 2017.
    Abstract     Related articles   

  144. CORSETTI M, Whorwell P
    New therapeutic options for IBS: the role of the first in class mixed micro- opioid receptor agonist and delta-opioid receptor antagonist (mudelta) eluxadoline.
    Expert Rev Gastroenterol Hepatol. 2017.
    Abstract     Related articles   

  145. LUNA RA, Oezguen N, Balderas M, Venkatachalam A, et al
    Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder.
    Cell Mol Gastroenterol Hepatol. 2016;3:218-230.
    Abstract     Related articles   

  146. MAILHE M, Ricaboni D, Benezech A, Lagier JC, et al
    'Tidjanibacter massiliensis' gen. nov., sp. nov., a new bacterial species isolated from human colon.
    New Microbes New Infect. 2016;17:21-22.
    Abstract     Related articles   

  147. DANTOFT TM, Ebstrup JF, Linneberg A, Skovbjerg S, et al
    Cohort description: The Danish study of Functional Disorders.
    Clin Epidemiol. 2017;9:127-139.
    Abstract     Related articles   

  148. VALENTIN N, Camilleri M, Carlson P, Harrington SC, et al
    Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome.
    Physiol Rep. 2017;5.
    Abstract     Related articles   

  149. SCHMULSON MJ, Drossman DA
    What is new in Rome IV.
    J Neurogastroenterol Motil. 2017 Mar 9. doi: 10.5056/jnm16214.
    Abstract     Related articles   

  150. GHOSHAL UC, Shukla R, Ghoshal U
    Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy.
    Gut Liver. 2017;11:196-208.
    Abstract     Related articles   

  151. BANIASADI N, Dehesh MM, Mohebbi E, Hayatbakhsh Abbasi M, et al
    Arq Gastroenterol. 2017 Feb 23:0. doi: 10.1590/S0004-2803.201700000.
    Abstract     Related articles   

  152. ZENTILIN P, Marabotto E, Pellegatta G, Coppo C, et al
    Complexity and diversity of GERD phenotypes.
    Minerva Gastroenterol Dietol. 2017 Mar 7. doi: 10.23736/S1121-421X.17.02399.
    Abstract     Related articles   

  153. HOD K, Sperber AD, Ron Y, Boaz M, et al
    A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS.
    Neurogastroenterol Motil. 2017 Mar 8. doi: 10.1111/nmo.13037.
    Abstract     Related articles   

  154. TSE Y, Armstrong D, Andrews CN, Bitton A, et al
    Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents.
    Can J Gastroenterol Hepatol. 2017;2017:8612189.
    Abstract     Related articles   

  155. SPIERLING SR, Zorrilla EP
    Don't stress about CRF: assessing the translational failures of CRF1antagonists.
    Psychopharmacology (Berl). 2017 Mar 7. doi: 10.1007/s00213-017-4556.
    Abstract     Related articles   

  156. MAO Q, Shi L, Wang ZG, Luo YH, et al
    Chemical profiles and pharmacological activities of Chang-Kang-Fang, a multi-herb Chinese medicinal formula, for treating irritable bowel syndrome.
    J Ethnopharmacol. 2017 Mar 2. pii: S0378-8741(17)30814.
    Abstract     Related articles   

  157. BOADAS-VAELLO P, Homs J, Reina F, Carrera A, et al
    Neuroplasticity of Supraspinal Structures Associated with Pathological Pain.
    Anat Rec (Hoboken). 2017 Mar 6. doi: 10.1002/ar.23587.
    Abstract     Related articles   

  158. DE BORTOLI N, Natali V, Melissari S, Simonetti N, et al
    Overlap of GERD and gastrointestinal functional disorders.
    Minerva Gastroenterol Dietol. 2017 Mar 3. doi: 10.23736/S1121-421X.17.02398.
    Abstract     Related articles   

  159. ARROUK R, Karpinski A, Lavenbarg T, Belmont J, et al
    Water Load Test in Children with Chronic Abdominal Pain or Obesity Compared with Nonobese Controls.
    South Med J. 2017;110:168-171.
    Abstract     Related articles   

  160. AZIZ I, Tornblom H, Simren M
    Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?
    Curr Opin Gastroenterol. 2017 Mar 2. doi: 10.1097/MOG.0000000000000348.
    Abstract     Related articles   

  161. ANASTASI JK, Capili B, Chang M
    Development of Acupuncture and Moxibustion Protocol in a Clinical Trial for Irritable Bowel Syndrome.
    J Acupunct Meridian Stud. 2017;10:62-66.
    Abstract     Related articles   

  162. LE DH
    Microbiome R&D and Business Collaboration Forum, April 11-12, 2016, London, UK.
    EBioMedicine. 2016;7:2-3.
    Abstract     Related articles   

  163. ZHANG NZ, Ma L, Jun C, Guo YX, et al
    Changes in mast cell infiltration: a possible mechanism in detrusor overactivity induced by visceral hypersensitivity.
    Int Braz J Urol. 2016;42:373-82.
    Abstract     Related articles   

  164. GROSJEAN D, Benini P, Carayon P
    Managing irritable bowel syndrome: The impact of micro-physiotherapy.
    J Complement Integr Med. 2017.
    Abstract     Related articles   

  165. TACK J, Drossman DA
    What's new in Rome IV?
    Neurogastroenterol Motil. 2017 Mar 17. doi: 10.1111/nmo.13053.
    Abstract     Related articles   

  166. MOORE JS, Gibson PR, Perry RE, Burgell RE, et al
    Endometriosis in patients with irritable bowel syndrome: Specific symptomatic and demographic profile, and response to the low FODMAP diet.
    Aust N Z J Obstet Gynaecol. 2017 Mar 17. doi: 10.1111/ajo.12594.
    Abstract     Related articles   

  167. JOHANSSON S, Rosenbaum DP, Ahlqvist M, Rollison H, et al
    Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.
    Clin Pharmacol Drug Dev. 2017 Mar 16. doi: 10.1002.
    Abstract     Related articles   

  168. CATASSI G, Lionetti E, Gatti S, Catassi C, et al
    The Low FODMAP Diet: Many Question Marks for a Catchy Acronym.
    Nutrients. 2017;9.
    Abstract     Related articles   

  169. HATTAY P, Prusator DK, Tran L, Greenwood-Van Meerveld B, et al
    Psychological stress-induced colonic barrier dysfunction: Role of immune-mediated mechanisms.
    Neurogastroenterol Motil. 2017 Mar 16. doi: 10.1111/nmo.13043.
    Abstract     Related articles   

  170. DOIRON PR, du P Menage H, Freeman A, Muneer A, et al
    Peri-meatal PeIN and urethral SCC: a case report.
    J Eur Acad Dermatol Venereol. 2017 Mar 10. doi: 10.1111/jdv.14207.
    Abstract     Related articles   

  171. CHEN A, Chen Y, Tang Y, Bao C, et al
    Hippocampal AMPARs involve the central sensitization of rats with irritable bowel syndrome.
    Brain Behav. 2017;7:e00650.
    Abstract     Related articles   

  172. IDA M, Nishida A, Akiho H, Nakashima Y, et al
    Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea.
    Biopsychosoc Med. 2017;11:7.
    Abstract     Related articles   

  173. PRISCO V, Iannaccone T
    [Inflammatory bowel disease and quality of life: psychopathological variants.]
    Recenti Prog Med. 2017;108:83-89.
    Abstract     Related articles   

  174. WILPART K, Tornblom H, Svedlund J, Tack JF, et al
    'Coping Skills are Associated With Gastrointestinal Symptom Severity and Somatization in Patients With Irritable Bowel Syndrome'.
    Clin Gastroenterol Hepatol. 2017 Mar 7. pii: S1542-3565(17)30263.
    Abstract     Related articles   

  175. OHLSSON B, Orho-Melander M, Nilsson PM
    Higher Levels of Serum Zonulin May Rather Be Associated with Increased Risk of Obesity and Hyperlipidemia, Than with Gastrointestinal Symptoms or Disease Manifestations.
    Int J Mol Sci. 2017;18.
    Abstract     Related articles   

  176. BAILEY C, Ruaux C, Stang BV, Valentine BA, et al
    Expression of serotonin, chromogranin-A, serotonin receptor-2B, tryptophan hydroxylase-1, and serotonin reuptake transporter in the intestine of dogs with chronic enteropathy.
    J Vet Diagn Invest. 2016;28:271-8.
    Abstract     Related articles   

  177. NEWLOVE-DELGADO TV, Martin AE, Abbott RA, Bethel A, et al
    Dietary interventions for recurrent abdominal pain in childhood.
    Cochrane Database Syst Rev. 2017;3:CD010972.
    Abstract     Related articles   

  178. BLONSKA A, Konrad P, Chojnacki J, Chojnacki C, et al
    [Evaluation of oro-cecal transit time in patients with irritable bowel syndrome with cereal products intolerance].
    Pol Merkur Lekarski. 2017;42:116-120.
    Abstract     Related articles   

  179. SCANZI F, Andreoli L, Martinelli M, Taraborelli M, et al
    Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures.
    Immunol Res. 2017 Mar 22. doi: 10.1007/s12026-017-8912.
    Abstract     Related articles   

  180. IDA M, Nishida A, Akiho H, Nakashima Y, et al
    Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea.
    Biopsychosoc Med. 2017;11:8.
    Abstract     Related articles   

  181. MA X, Wang X, Kang N, Chen T, et al
    The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats.
    Evid Based Complement Alternat Med. 2017;2017:9086034.
    Abstract     Related articles   

  182. NAKAO JH, Collier SA, Gargano JW
    Giardiasis and Subsequent Irritable Bowel Syndrome: A Longitudinal Cohort Study Using Health Insurance Data.
    J Infect Dis. 2017 Feb 23. doi: 10.1093.
    Abstract     Related articles   

  183. BOWERS H, Wroe A, Pincus T
    The relationship between beliefs about emotions and quality of life in irritable bowel syndrome.
    Psychol Health Med. 2017 Mar 22:1-7. doi: 10.1080/13548506.2017.1307996.
    Abstract     Related articles   

  184. SHERWIN LB, Leary E, Henderson WA
    The association of catastrophizing with quality-of-life outcomes in patients with irritable bowel syndrome.
    Qual Life Res. 2017 Mar 21. doi: 10.1007/s11136-017-1554.
    Abstract     Related articles   

  185. TOUW K, Ringus DL, Hubert N, Wang Y, et al
    Mutual reinforcement of pathophysiological host-microbe interactions in intestinal stasis models.
    Physiol Rep. 2017;5.
    Abstract     Related articles   

  186. PARK A, Conway M
    Longitudinal Changes in Psychological States in Online Health Community Members: Understanding the Long-Term Effects of Participating in an Online Depression Community.
    J Med Internet Res. 2017;19:e71.
    Abstract     Related articles   

  187. AL-MOZANY N, Wright C, O'Grady G, Young CJ, et al
    Barriers to the management of obstructed defecation according to colorectal surgeons.
    Colorectal Dis. 2017 Mar 20. doi: 10.1111/codi.13665.
    Abstract     Related articles   

  188. MOHAMMADI M, Tahmasebi Abdar H, Mollaei HR, Hajghani H, et al
    Serotonin Transporter Gene (SLC6A4) Polymorphism and Mucosal Serotonin Levels in Southeastern Iranian Patients with Irritable Bowel Syndrome.
    Middle East J Dig Dis. 2017;9:26-32.
    Abstract     Related articles   

  189. GHADIR MR, Poradineh M, Sotodeh M, Ansari R, et al
    Mesalazine Has No Effect on Mucosal Immune Biomarkers in Patients with Diarrhea-Dominant Irritable Bowel Syndrome Referred to Shariati Hospital: A Randomized Double-Blind, Placebo-Controlled Trial.
    Middle East J Dig Dis. 2017;9:20-25.
    Abstract     Related articles   

  190. MANCEAU H, Chicha-Cattoir V, Puy H, Peoc'h K, et al
    Fecal calprotectin in inflammatory bowel diseases: update and perspectives.
    Clin Chem Lab Med. 2017;55:474-483.
    Abstract     Related articles   

  191. BRANCALE A, Shailubhai K, Ferla S, Ricci A, et al
    Therapeutically targeting guanylate cyclase-C: computational modeling of plecanatide, a uroguanylin analog.
    Pharmacol Res Perspect. 2017;5:e00295.
    Abstract     Related articles   

  192. IBRAHIM NK, Al-Bloushy RI, Sait SH, Al-Azhary HW, et al
    Irritable bowel syndrome among nurses working in King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
    Libyan J Med. 2016;11:30866.
    Abstract     Related articles   

  193. ABRAHAMSSON TR, Wu RY, Sherman PM
    Microbiota in Functional Gastrointestinal Disorders in Infancy: Implications for Management.
    Nestle Nutr Inst Workshop Ser. 2017;88:107-115.
    Abstract     Related articles   

  194. RUTTEN JM, Vlieger AM, Frankenhuis C, George EK, et al
    Home-Based Hypnotherapy Self-exercises vs Individual Hypnotherapy With a Therapist for Treatment of Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, or Functional Abdominal Pain Syndrome: A Randomized Clinical Trial.
    JAMA Pediatr. 2017 Mar 27. doi: 10.1001/jamapediatrics.2017.0091.
    Abstract     Related articles   

  195. ESWARAN S
    Low FODMAP in 2017: Lessons learned from clinical trials and mechanistic studies.
    Neurogastroenterol Motil. 2017;29.
    Abstract     Related articles   

  196. JUSZCZUK K, Grudlewska K, Mikucka A, Gospodarek E, et al
    Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.
    Postepy Hig Med Dosw (Online). 2017;71:220-226.
    Abstract     Related articles   

  197. BUONO JL, Mathur K, Averitt AJ, Andrae DA, et al
    Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
    J Manag Care Spec Pharm. 2017;23:453-460.
    Abstract     Related articles   

  198. YAO CK, Tuck CJ, Barrett JS, Canale KE, et al
    Poor reproducibility of breath hydrogen testing: Implications for its application in functional bowel disorders.
    United European Gastroenterol J. 2017;5:284-292.
    Abstract     Related articles   

  199. MELCHIOR C, Aziz M, Aubry T, Gourcerol G, et al
    Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study.
    United European Gastroenterol J. 2017;5:261-269.
    Abstract     Related articles   

  200. ERICKSON J, Wang Q, Slavin J
    White Grape Juice Elicits a Lower Breath Hydrogen Response Compared with Apple Juice in Healthy Human Subjects: A Randomized Controlled Trial.
    J Acad Nutr Diet. 2017 Mar 22. pii: S2212-2672(17)30102.
    Abstract     Related articles   

  201. SZNURKOWSKA K, Zawrocki A, Sznurkowski J, Izycka-Swieszewska E, et al
    Indoleamine 2,3-dioxygenase and regulatory t cells in intestinal mucosa in children with inflammatory bowel disease.
    J Biol Regul Homeost Agents. 2017;31:125-131.
    Abstract     Related articles   

  202. BALEMANS D, Boeckxstaens GE, Talavera K, Wouters MM, et al
    Transient Receptor Potential Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades Underlying Visceral Hypersensitivity.
    Am J Physiol Gastrointest Liver Physiol. 2017 Apr 6:ajpgi.00401.2016.
    Abstract     Related articles   

  203. HARVIE DS, Moseley GL, Hillier SL, Meulders A, et al
    Classical conditioning differences associated with chronic pain: a systematic review.
    J Pain. 2017 Apr 3. pii: S1526-5900(17)30484-4. doi: 10.1016/j.jpain.2017.
    Abstract     Related articles   

  204. SIDDIQUI S, Misra SP, Dwivedi M, Pant S, et al
    Irritable Bowel Syndrome and Bronchial Asthma: Are They Associated in Indian Population?
    J Clin Diagn Res. 2017;11:OC21-OC23.
    Abstract     Related articles   

  205. YANG TY, Chen CS, Lin CL, Lin WM, et al
    Risk for Irritable Bowel Syndrome in Fibromyalgia Patients: A National Database Study.
    Medicine (Baltimore). 2017;96:e6657.
    Abstract     Related articles   

  206. SIDHU M, van der Poorten D
    The gut microbiome.
    Aust Fam Physician. 2017;46:206-211.
    Abstract     Related articles   

  207. MEURET AE, Kroll J, Ritz T
    Panic Disorder Comorbidity with Medical Conditions and Treatment Implications.
    Annu Rev Clin Psychol. 2017 Mar 27. doi: 10.1146/annurev-clinpsy-021815-093044.
    Abstract     Related articles   

  208. LACY BE
    Hot Topics in Primary Care: Role of the Microbiome in Disease: Implications for Treatment of Irritable Bowel Syndrome.
    J Fam Pract. 2017;66.
    Abstract     Related articles   

  209. OSTERTAG D, Annahazi A, Krueger D, Michel K, et al
    Tryptase potentiates enteric nerve activation by histamine and serotonin: Relevance for the effects of mucosal biopsy supernatants from irritable bowel syndrome patients.
    Neurogastroenterol Motil. 2017 Apr 4. doi: 10.1111/nmo.13070.
    Abstract     Related articles   

  210. SIMREN M, Palsson OS, Whitehead WE
    Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice.
    Curr Gastroenterol Rep. 2017;19:15.
    Abstract     Related articles   

  211. ANDREOLI L, Tincani A
    Undifferentiated connective tissue disease, fibromyalgia and the environmental factors.
    Curr Opin Rheumatol. 2017 Mar 31. doi: 10.1097/BOR.0000000000000392.
    Abstract     Related articles   

  212. ERBASAN F, Cekin Y, Coban DT, Karasu U, et al
    The Frequency of Primary Sjogren's Syndrome and Fibromyalgia in Irritable Bowel Syndrome.
    Pak J Med Sci. 2017;33:137-141.
    Abstract     Related articles   

  213. ALAQEEL MK, Alowaimer NA, Alonezan AF, Almegbel NY, et al
    Prevalence of Irritable Bowel Syndrome and its Association with Anxiety among Medical Students at King Saud bin Abdulaziz University for Health Sciences in Riyadh.
    Pak J Med Sci. 2017;33:33-36.
    Abstract     Related articles   

  214. ISHIMOTO H, Oshima T, Sei H, Yamasaki T, et al
    Claudin-2 expression is upregulated in the ileum of diarrhea predominant irritable bowel syndrome patients.
    J Clin Biochem Nutr. 2017;60:146-150.
    Abstract     Related articles   

  215. AGGER JL, Schroder A, Gormsen LK, Jensen JS, et al
    Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study.
    Lancet Psychiatry. 2017 Apr 10. pii: S2215-0366(17)30126.
    Abstract     Related articles   

  216. FEHNEL SE, Ervin CM, Carson RT, Rigoni G, et al
    Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Value Health. 2017;20:618-626.
    Abstract     Related articles   

  217. NGUYEN TT, Dau DT, Nguyen DC, Nguyen HT, et al
    Effects of Trang Phuc Linh Plus-Food Supplement on Irritable Bowel Syndrome Induced by Mustard Oil.
    J Med Food. 2017;20:385-391.
    Abstract     Related articles   

  218. FLIK CE, Bakker L, Laan W, van Rood YR, et al
    Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome.
    World J Gastroenterol. 2017;23:2223-2233.
    Abstract     Related articles   

  219. HOLTMANN GJ, Ford AC, Talley NJ
    Pathophysiology of irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2016;1:133-146.
    Abstract     Related articles   

  220. LE GAL J, Michel JF, Rinaldi VE, Spiri D, et al
    Association between functional gastrointestinal disorders and migraine in children and adolescents: a case-control study.
    Lancet Gastroenterol Hepatol. 2016;1:114-121.
    Abstract     Related articles   

  221. SIMREN M, Tornblom H, Palsson OS, Whitehead WE, et al
    Management of the multiple symptoms of irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2017;2:112-122.
    Abstract     Related articles   

  222. CHUTIMA R, Kanchanatawan B, Sirivichayakul S, Anderson G, et al
    IgA/IgM Responses to Gram-Negative Bacteria are not Associated with Perinatal Depression, but with Physio-Somatic Symptoms and Activation of the Tryptophan Catabolite Pathway at the End of Term and Postnatal Anxiety.
    CNS Neurol Disord Drug Targets. 2017.
    Abstract     Related articles   

  223. TSIGARIDAS A, Papanikolaou IS, Vaiopoulou A, Anagnostopoulos AK, et al
    Proteomics and Irritable Bowel Syndrome.
    Expert Rev Proteomics. 2017 Apr 11. doi: 10.1080/14789450.2017.1317600.
    Abstract     Related articles   

  224. CHEN CY, Zhang M, Wang SS, Lu B, et al
    [Changes of adherens junctions between the epithelial cells of intestinal mucosal barrier in irritable bowel syndrome].
    Zhonghua Yi Xue Za Zhi. 2017;97:1065-1070.
    Abstract     Related articles   

  225. DINDO L, Lackner J
    The impact of different coping strategies on the physical and mental health of irritable bowel syndrome patients.
    Clin Gastroenterol Hepatol. 2017 Apr 6. pii: S1542-3565(17)30396.
    Abstract     Related articles   

  226. FUKE N, Aizawa K, Suganuma H, Takagi T, et al
    Effect of combined consumption of Lactobacillus brevis KB290 and beta-carotene on minor diarrhoea-predominant irritable bowel syndrome-like symptoms in healthy subjects: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Int J Food Sci Nutr. 2017 Apr 9:1-14. doi: 10.1080/09637486.2017.1311843.
    Abstract     Related articles   

  227. MARTINEZ KB, Leone VA, Chang EB
    Microbial Metabolites in Health and Disease: Navigating the Unknown in Search of Function.
    J Biol Chem. 2017 Apr 7. pii: jbc.R116.752899. doi: 10.1074/jbc.R116.752899.
    Abstract     Related articles   

  228. MADISCH A, Vinson BR, Abdel-Aziz H, Kelber O, et al
    Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.
    Wien Med Wochenschr. 2017 Apr 19. doi: 10.1007/s10354-017-0557.
    Abstract     Related articles   

  229. SUNDIN J, Ohman L, Simren M
    Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases.
    Psychosom Med. 2017 Apr 18. doi: 10.1097/PSY.0000000000000470.
    Abstract     Related articles   

  230. BAYLESS TM, Brown E, Paige DM
    Lactase Non-persistence and Lactose Intolerance.
    Curr Gastroenterol Rep. 2017;19:23.
    Abstract     Related articles   

  231. HILL P, Muir JG, Gibson PR
    Controversies and Recent Developments of the Low-FODMAP Diet.
    Gastroenterol Hepatol (N Y). 2017;13:36-45.
    Abstract     Related articles   

  232. PARK YM, Lee YJ, Hussain Z, Lee YH, et al
    The effects and mechanism of action of methane on ileal motor function.
    Neurogastroenterol Motil. 2017 Apr 18. doi: 10.1111/nmo.13077.
    Abstract     Related articles   

  233. CHAI Y, Huang Y, Tang H, Tu X, et al
    Role of stem cell growth factor/c-Kit in the pathogenesis of irritable bowel syndrome.
    Exp Ther Med. 2017;13:1187-1193.
    Abstract     Related articles   

  234. COMPARE D, Rocco A, Coccoli P, Angrisani D, et al
    Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome.
    BMC Gastroenterol. 2017;17:53.
    Abstract     Related articles   

    [Not Available].
    Lakartidningen. 2016;113.
    Abstract     Related articles   

  236. REED-KNIGHT B, Claar RL, Schurman JV, van Tilburg MA, et al
    Implementing psychological therapies for functional GI disorders in children and adults.
    Expert Rev Gastroenterol Hepatol. 2016;10:981-4.
    Abstract     Related articles   

  237. HEIDARI F, Afshari M, Moosazadeh M
    Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis.
    Rheumatol Int. 2017 Apr 26. doi: 10.1007/s00296-017-3725.
    Abstract     Related articles   

  238. MCCULLOUGH R, McCullough J
    Deciphering the pathophysiology of irritable bowel syndrome and functional gastrointestinal disorders-an alternative model for pathogenesis: cytokine controlled transepithelial multi-feedback loop.
    Transl Gastroenterol Hepatol. 2017;2:18.
    Abstract     Related articles   

  239. IKECHI R, Fischer BD, DeSipio J, Phadtare S, et al
    Irritable Bowel Syndrome: Clinical Manifestations, Dietary Influences, and Management.
    Healthcare (Basel). 2017;5.
    Abstract     Related articles   

  240. NAGY-SZAKAL D, Williams BL, Mishra N, Che X, et al
    Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Microbiome. 2017;5:44.
    Abstract     Related articles   

  241. REN YJ, Zhang L, Bai T, Yu HL, et al
    Transfer of CD11c+ lamina propria mononuclear phagocytes from post-infectious irritable bowel syndrome causes mucosal barrier dysfunction and visceral hypersensitivity in recipient mice.
    Int J Mol Med. 2017 Apr 25. doi: 10.3892/ijmm.2017.2966.
    Abstract     Related articles   

  242. ALLEN AP, Clarke G, Cryan JF, Quigley EMM, et al
    Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms and mechanisms.
    Curr Med Res Opin. 2017 Apr 22:1-8. doi: 10.1080/03007995.2017.1322571.
    Abstract     Related articles   

  243. JOHANSSON S, Rosenbaum DP, Palm J, Stefansson B, et al
    Tenapanor administration and the activity of the H+ -coupled transporter PepT1 in healthy volunteers.
    Br J Clin Pharmacol. 2017 Apr 22. doi: 10.1111/bcp.13313.
    Abstract     Related articles   

  244. BORTOLATO B, Kohler CA, Evangelou E, Leon-Caballero J, et al
    Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses.
    Bipolar Disord. 2017 May 3. doi: 10.1111/bdi.12490.
    Abstract     Related articles   

  245. MACONI G
    Diagnosis of symptomatic uncomplicated diverticular disease and the role of Rifaximin in management.
    Acta Biomed. 2017;88:25-32.
    Abstract     Related articles   

  246. DI STEFANO M, Bergonzi M, Miceli E, Klersy C, et al
    In irritable bowel syndrome, postprandial abdominal distention is associated with a reduction of intestinal tone.
    Neurogastroenterol Motil. 2017 May 3. doi: 10.1111/nmo.13098.
    Abstract     Related articles   

    [New options in the tratment of irritable bowel syndrome].
    MMW Fortschr Med. 2017;159:57-60.
    Abstract     Related articles   

  248. HESSER H, Hedman E, Lindfors P, Andersson E, et al
    The specific effect of systematic exposure in irritable bowel syndrome: complier average causal effect analysis using growth mixture modeling.
    Psychol Med. 2017 May 3:1-10. doi: 10.1017/S0033291717001167.
    Abstract     Related articles   

  249. PORTINCASA P, Lembo A, De Bari O, Di Palo DM, et al
    The role of dietary approach in irritable bowel syndrome.
    Curr Med Chem. 2017 Apr 27. doi: 10.2174/0929867324666170428102451.
    Abstract     Related articles   

  250. STASI C, Bellini M, Gambaccini D, Duranti E, et al
    Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study.
    J Neurogastroenterol Motil. 2017 Apr 26. doi: 10.5056/jnm16155.
    Abstract     Related articles   

  251. KATSUMATA R, Shiotani A, Murao T, Ishii M, et al
    Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome.
    Intern Med. 2017;56:993-999.
    Abstract     Related articles   

  252. ENGELHART S, Glynn RJ, Schur PH
    Disease associations with isolated elevations of each of the four IgG subclasses.
    Semin Arthritis Rheum. 2017 Mar 30. pii: S0049-0172(16)30325.
    Abstract     Related articles   

  253. LABUS JS, Hollister EB, Jacobs J, Kirbach K, et al
    Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
    Microbiome. 2017;5:49.
    Abstract     Related articles   

  254. PARK BK, Chun E, Choi JJ, Shin Y, et al
    Administration of Wasabia koreana Ameliorates Irritable Bowel Syndrome-Like Symptoms in a Zymosan-Induced Mouse Model.
    J Med Food. 2017 Apr 28. doi: 10.1089/jmf.2016.3844.
    Abstract     Related articles   

  255. CHARLESWORTH JEG, Petkovic G, Kelley JM, Hunter M, et al
    Effects of placebos without deception compared with no treatment: a systematic review and meta-analysis.
    J Evid Based Med. 2017 Apr 27. doi: 10.1111/jebm.12251.
    Abstract     Related articles   

  256. CIAMPA BP, Reyes Ramos E, Borum M, Doman DB, et al
    The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders.
    Gastroenterol Hepatol (N Y). 2017;13:104-115.
    Abstract     Related articles   

  257. KANO M, Muratsubaki T, Morishita J, Kono K, et al
    Influence of uncertain anticipation on brain responses to aversive rectal distension in patients with irritable bowel syndrome.
    Psychosom Med. 2017 May 12. doi: 10.1097/PSY.0000000000000484.
    Abstract     Related articles   

  258. MADANI S, Parikh S, Madani RS, Krasaelap A, et al
    Long-Term Study of Children With ROME III Functional Gastrointestinal Disorders Managed Symptomatically in a Biopsychosocial Model.
    Gastroenterology Res. 2017;10:84-91.
    Abstract     Related articles   

  259. REZAPOUR M, Ali S, Stollman N
    Diverticular Disease: An Update on Pathogenesis and Management.
    Gut Liver. 2017 May 12. doi: 10.5009/gnl16552.
    Abstract     Related articles   

  260. SULABERIDZE G, Okujava M, Liluashvili K, Tughushi M, et al
    Georgian Med News. 2017;:132-135.
    Abstract     Related articles   

  261. JANG A, Hwang SK, Padhye NS, Meininger JC, et al
    Effects of Cognitive Behavior Therapy on Heart Rate Variability in Young Females with Constipation-predominant Irritable Bowel Syndrome: A Parallel-group Trial.
    J Neurogastroenterol Motil. 2017 May 8. doi: 10.5056/jnm17017.
    Abstract     Related articles   

  262. JUNG SE, Joo NS, Han KS, Kim KN, et al
    Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.
    J Korean Med Sci. 2017;32:948-953.
    Abstract     Related articles   

  263. KENWRIGHT M, McDonald J, Talbot J, Janjua K, et al
    Do Symptoms of Irritable Bowel Syndrome Improve when Patients Receive Cognitive Behavioural Therapy for Co-morbid Anxiety Disorders in a Primary Care Psychological Therapy (IAPT) Service?
    Behav Cogn Psychother. 2017 May 8:1-15. doi: 10.1017/S1352465817000200.
    Abstract     Related articles   

  264. SILVERMAN SL, Backonja M, Pauer L, Landen J, et al
    Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid Depression.
    Pain Med. 2017 May 19. doi: 10.1093.
    Abstract     Related articles   

  265. COX SR, Prince AC, Myers CE, Irving PM, et al
    Fermentable carbohydrates (FODMAPs) exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial.
    J Crohns Colitis. 2017 May 19. doi: 10.1093.
    Abstract     Related articles   

  266. CHAO G, Zhang S
    Aquaporins 1, 3 and 8 expression in irritable bowel syndrome rats' colon via NF-kappaB pathway.
    Oncotarget. 2017 May 2. doi: 10.18632/oncotarget.17565.
    Abstract     Related articles   

  267. MIZUKAMI T, Sugimoto S, Masaoka T, Suzuki H, et al
    Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome.
    Intest Res. 2017;15:236-243.
    Abstract     Related articles   

  268. KUMAR S, Bopanna S, Kedia S, Mouli P, et al
    Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis.
    Intest Res. 2017;15:187-194.
    Abstract     Related articles   

  269. ZHAO JM, Li L, Chen L, Shi Y, et al
    Comparison of the analgesic effects between electro-acupuncture and moxibustion with visceral hypersensitivity rats in irritable bowel syndrome.
    World J Gastroenterol. 2017;23:2928-2939.
    Abstract     Related articles   

  270. GAO M, Zhong A, Patel N, Alur C, et al
    High throughput RNA sequencing utility for diagnosis and prognosis in colon diseases.
    World J Gastroenterol. 2017;23:2819-2825.
    Abstract     Related articles   

  271. JARBOL DE, Rasmussen S, Balasubramaniam K, Elnegaard S, et al
    Self-rated health and functional capacity in individuals reporting overlapping symptoms of gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome - a population based study.
    BMC Gastroenterol. 2017;17:65.
    Abstract     Related articles   

  272. STEFFEN R
    Epidemiology of travellers' diarrhea.
    J Travel Med. 2017;24.
    Abstract     Related articles   

  273. KARKAR R, Schroeder J, Epstein DA, Pina LR, et al
    TummyTrials: A Feasibility Study of Using Self-Experimentation to Detect Individualized Food Triggers.
    Proc SIGCHI Conf Hum Factor Comput Syst. 2017;2017:6850-6863.
    Abstract     Related articles   

  274. SCHROEDER J, Hoffswell J, Chung CF, Fogarty J, et al
    Supporting Patient-Provider Collaboration to Identify Individual Triggers using Food and Symptom Journals.
    Comput Support Coop Work. 2017;2017:1726-1739.
    Abstract     Related articles   

  275. DEHKORDI AH, Solati K
    The effects of cognitive behavioral therapy and drug therapy on quality of life and symptoms of patients with irritable bowel syndrome.
    J Adv Pharm Technol Res. 2017;8:67-72.
    Abstract     Related articles   

  276. GOYAL M, Goyal K, Bathla M, Kanimozhi D, et al
    Efficacy of Myofascial Unwinding and Myofascial Release Technique in a Patient with Somatic Symptoms - A Case Report.
    Indian J Psychol Med. 2017;39:199-201.
    Abstract     Related articles   

  277. PARFENOV AI, Akhmadullina OV, Sabelnikova EA, Belostotsky NI, et al
    [Disaccharidase deficiency and functional bowel diseases].
    Ter Arkh. 2017;89:45-52.
    Abstract     Related articles   

  278. YANG Q, Xu X, Zhao H, Cai Y, et al
    Differential expression of microRNAs related to irritable bowel syndrome in a rabbit model.
    J Dig Dis. 2017 May 16. doi: 10.1111/1751-2980.12485.
    Abstract     Related articles   

  279. ALT F, Chong PW, Teng E, Uebelhack R, et al
    Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled Clinical Trial.
    Phytother Res. 2017 May 16. doi: 10.1002/ptr.5826.
    Abstract     Related articles   

  280. APPLEBY RN, Bajor A, Gillberg PG, Graffner H, et al
    Effects of conventional and a novel colonic-release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea.
    United European Gastroenterol J. 2017;5:380-388.
    Abstract     Related articles   

  281. LEPAGE P
    [The human gut microbiota: Interactions with the host and dysfunctions].
    Rev Mal Respir. 2017 May 12. pii: S0761-8425(17)30047.
    Abstract     Related articles   

  282. CHOGHAKHORI R, Abbasnezhad A, Hasanvand A, Amani R, et al
    Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: Association with digestive symptoms and quality of life.
    Cytokine. 2017 May 12. pii: S1043-4666(17)30126.
    Abstract     Related articles   

  283. DOSSETT ML, Cohen EM, Cohen J
    Integrative Medicine for Gastrointestinal Disease.
    Prim Care. 2017;44:265-280.
    Abstract     Related articles   

  284. ERICKSON J, Korczak R, Wang Q, Slavin J, et al
    Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial.
    Nutr J. 2017;16:35.
    Abstract     Related articles   

  285. BALLOU S, Kaptchuk TJ, Hirsch W, Nee J, et al
    Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial.
    Trials. 2017;18:234.
    Abstract     Related articles   

  286. KURLANDER JE, Chey WD, Morris CB, Hu YJB, et al
    Development and validation of the Patient-Physician Relationship Scale among patients with irritable bowel syndrome.
    Neurogastroenterol Motil. 2017 May 22. doi: 10.1111/nmo.13106.
    Abstract     Related articles   

  287. WEAVER KR, Melkus GD, Henderson WA
    Irritable Bowel Syndrome.
    Am J Nurs. 2017;117:48-55.
    Abstract     Related articles   

  288. HUSSAIN Z, Kim HW, Huh CW, Lee YJ, et al
    The Effect of Peripheral CRF Peptide and Water Avoidance Stress on Colonic and Gastric Transit in Guinea Pigs.
    Yonsei Med J. 2017;58:872-877.
    Abstract     Related articles   

  289. BELCARO G, Gizzi G, Pellegrini L, Corsi M, et al
    Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome(R)) controls symptoms of mild irritable bowel syndrome.
    Eur Rev Med Pharmacol Sci. 2017;21:2249-2254.
    Abstract     Related articles   

  290. CAMILLERI M, Lembo A, Katzka DA
    Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits.
    Clin Gastroenterol Hepatol. 2017 May 18. pii: S1542-3565(17)30589.
    Abstract     Related articles   

  291. WINDGASSEN S, Moss-Morris R, Chilcot J, Sibelli A, et al
    The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome.
    Br J Health Psychol. 2017 Jun 1. doi: 10.1111/bjhp.12250.
    Abstract     Related articles   

  292. BELLINI M, Gambaccini D, Bazzichi L, Bassotti G, et al
    Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study.
    Tech Coloproctol. 2017 May 31. doi: 10.1007/s10151-017-1639.
    Abstract     Related articles   

  293. PEDERSEN N, Ankersen DV, Felding M, Wachmann H, et al
    Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease.
    World J Gastroenterol. 2017;23:3356-3366.
    Abstract     Related articles   

  294. LIM SK, Yoo SJ, Koo DL, Park CA, et al
    Stress and sleep quality in doctors working on-call shifts are associated with functional gastrointestinal disorders.
    World J Gastroenterol. 2017;23:3330-3337.
    Abstract     Related articles   

  295. KRARUP AL, Engsbro ALO, Fassov J, Fynne L, et al
    Danish national guideline: Diagnosis and treatment of Irritable Bowel Syndrome.
    Dan Med J. 2017;64.
    Abstract     Related articles   

  296. IACOB T, Tatulescu DF, Dumitrascu DL
    Therapy of the postinfectious irritable bowel syndrome: an update.
    Clujul Med. 2017;90:133-138.
    Abstract     Related articles   

  297. BAYER SB, Gearry RB, Drummond LN
    Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function.
    Crit Rev Food Sci Nutr. 2017 May 30:0. doi: 10.1080/10408398.2017.1327841.
    Abstract     Related articles   

  298. JONSSON IM, Moller GL, Paerregaard A
    [Gluten-free diet is for some a necessity, for others a lifestyle].
    Ugeskr Laeger. 2017;179.
    Abstract     Related articles   

  299. FABISIAK A, Wlodarczyk J, Fabisiak N, Storr M, et al
    Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal.
    J Neurogastroenterol Motil. 2017 May 27. doi: 10.5056/jnm16203.
    Abstract     Related articles   

  300. LIN WT, Liao YJ, Peng YC, Chang CH, et al
    Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study.
    World J Gastroenterol. 2017;23:3513-3521.
    Abstract     Related articles   

  301. AHSAN MK, Tchernychev B, Kessler MM, Solinga RM, et al
    Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-II-dependent trafficking of CFTR in the intestine.
    Physiol Rep. 2017;5.
    Abstract     Related articles   

  302. LEE J, Hong KS, Kim JS, Jung HC, et al
    Balloon Expulsion Test Does Not Seem to Be Useful for Screening or Exclusion of Dyssynergic Defecation as a Single Test.
    J Neurogastroenterol Motil. 2017 Jun 4. doi: 10.5056/jnm16158.
    Abstract     Related articles   

    The low FODMAP diet: fundamental therapy in the management of irritable bowel syndrome.
    Curr Opin Clin Nutr Metab Care. 2017 Jun 14. doi: 10.1097/MCO.0000000000000398.
    Abstract     Related articles   

  304. SHAW AL, Tomanelli A, Bradshaw TP, Petschow BW, et al
    Impact of serum-derived bovine immunoglobulin/protein isolate therapy on irritable bowel syndrome and inflammatory bowel disease: a survey of patient perspective.
    Patient Prefer Adherence. 2017;11:1001-1007.
    Abstract     Related articles   

  305. TAYAMA J, Saigo T, Ogawa S, Takeoka A, et al
    Effect of attention bias modification on brain function and anxiety in patients with irritable bowel syndrome: A preliminary electroencephalogram and psycho-behavioral study.
    Neurogastroenterol Motil. 2017 Jun 14. doi: 10.1111/nmo.13131.
    Abstract     Related articles   

  306. SIRRI L, Grandi S, Tossani E
    Smoking in Irritable Bowel Syndrome: A Systematic Review.
    J Dual Diagn. 2017 Jun 13:1-17. doi: 10.1080/15504263.2017.1322226.
    Abstract     Related articles   

  307. PEERY AF, Keku TO, Addamo C, McCoy AN, et al
    Colonic Diverticula Are Not Associated with Mucosal Inflammation or Chronic Gastrointestinal Symptoms.
    Clin Gastroenterol Hepatol. 2017 Jun 8. pii: S1542-3565(17)30694.
    Abstract     Related articles   

  308. XU XJ, Yao SK
    Editorial: increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome. Authors' reply.
    Aliment Pharmacol Ther. 2017;45:568-569.
    Abstract     Related articles   

  309. BENNET SM, Tornblom H
    Editorial: increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome.
    Aliment Pharmacol Ther. 2017;45:567-568.
    Abstract     Related articles   

  310. SOOD R, Ford AC
    Editorial: volatile organic compounds in irritable bowel syndrome - technology for an accurate and reliable point-of-care test?
    Aliment Pharmacol Ther. 2017;45:563-564.
    Abstract     Related articles   

  311. SOOD R, Gracie DJ, Gold MJ, To N, et al
    Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis.
    Aliment Pharmacol Ther. 2017 Jan 20. doi: 10.1111/apt.13949.
    Abstract     Related articles   

  312. CREMON C, Stanghellini V, Barbaro MR, Cogliandro RF, et al
    Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2017 Feb 6. doi: 10.1111/apt.13958.
    Abstract     Related articles   

  313. PORTER CK, Welsh M, Riddle MS, Nieh C, et al
    Epidemiology of inflammatory bowel disease among participants of the Millennium Cohort: incidence, deployment-related risk factors, and antecedent episodes of infectious gastroenteritis.
    Aliment Pharmacol Ther. 2017 Feb 23. doi: 10.1111/apt.13991.
    Abstract     Related articles   

  314. WHITEHEAD WE, Duffy K, Sharpe J, Nabata T, et al
    Editorial: ONO-2952 in irritable bowel syndrome with diarrhoea - authors' reply.
    Aliment Pharmacol Ther. 2017;45:1005.
    Abstract     Related articles   

  315. NEE J, Lembo A
    Editorial: ONO-2952 in irritable bowel syndrome with diarrhoea.
    Aliment Pharmacol Ther. 2017;45:1004-1005.
    Abstract     Related articles   

    Editorial: metabolic adaptation of colonic microbiota to galactooligosaccharides - good news for prebiotics in irritable bowel syndrome?
    Aliment Pharmacol Ther. 2017;45:1005-1006.
    Abstract     Related articles   

  317. CHEY WD, Dove LS, Andrae DA, Covington PS, et al
    Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies.
    Aliment Pharmacol Ther. 2017 Mar 22. doi: 10.1111/apt.14031.
    Abstract     Related articles   

    Editorial: diet, inflammation and irritable bowel syndrome.
    Aliment Pharmacol Ther. 2017;45:1278-1279.
    Abstract     Related articles   

  319. KROGSGAARD LR, Lyngesen M, Bytzer P
    Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome.
    Aliment Pharmacol Ther. 2017 Apr 25. doi: 10.1111/apt.14065.
    Abstract     Related articles   

  320. KARUPPIAH S, Pomianowski K
    Rifaximin (Xifaxan) for Irritable Bowel Syndrome.
    Am Fam Physician. 2017;95:258-259.
    Abstract     Related articles   

  321. CHANG BW, Rezaie A
    Irritable Bowel Syndrome-Like Symptoms Following Fecal Microbiota Transplantation: A Possible Donor-Dependent Complication.
    Am J Gastroenterol. 2017;112:186-187.
    Abstract     Related articles   

  322. SAYUK GS, Wolf R, Chang L
    Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome.
    Am J Gastroenterol. 2017 Jan 17. doi: 10.1038/ajg.2016.
    Abstract     Related articles   

  323. CHEY WD, Lembo AJ, Rosenbaum DP
    Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial.
    Am J Gastroenterol. 2017 Feb 28. doi: 10.1038/ajg.2017.
    Abstract     Related articles   

  324. PETERS SA, Edogawa S, Sundt WJ, Dyer RB, et al
    Constipation-Predominant Irritable Bowel Syndrome Females Have Normal Colonic Barrier and Secretory Function.
    Am J Gastroenterol. 2017 Mar 21. doi: 10.1038/ajg.2017.
    Abstract     Related articles   

  325. LACY BE, Chey WD, Cash BD, Lembo AJ, et al
    Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use.
    Am J Gastroenterol. 2017 Apr 18. doi: 10.1038/ajg.2017.
    Abstract     Related articles   

  326. MALAGELADA JR, Accarino A, Azpiroz F
    Bloating and Abdominal Distension: Old Misconceptions and Current Knowledge.
    Am J Gastroenterol. 2017 May 16. doi: 10.1038/ajg.2017.
    Abstract     Related articles   

  327. KESZTHELYI D, Ringel Y
    Editorial: Clinical Implications of Diagnosing Irritable Bowel Syndrome: Do All Roads Need to Lead to Rome?
    Am J Gastroenterol. 2017;112:900-902.
    Abstract     Related articles   

  328. SULTAN S, Malhotra A
    Irritable Bowel Syndrome.
    Ann Intern Med. 2017;166:ITC81-ITC96.
    Abstract     Related articles   

  329. GUDLESKI GD, Satchidanand N, Dunlap LJ, Tahiliani V, et al
    Predictors of medical and mental health care use in patients with irritable bowel syndrome in the United States.
    Behav Res Ther. 2017;88:65-75.
    Abstract     Related articles   

  330. JOYCE SA, Gahan CG
    Disease-Associated Changes in Bile Acid Profiles and Links to Altered Gut Microbiota.
    Dig Dis. 2017;35:169-177.
    Abstract     Related articles   

  331. BHANDARI S, Venkatesan T
    Clinical Characteristics, Comorbidities and Hospital Outcomes in Hospitalizations with Cyclic Vomiting Syndrome: A Nationwide Analysis.
    Dig Dis Sci. 2017 Jan 3. doi: 10.1007/s10620-016-4432.
    Abstract     Related articles   

  332. HSU CS, Wen SH, Hung JS, Liu TT, et al
    Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics.
    Dig Dis Sci. 2017 Jan 23. doi: 10.1007/s10620-017-4455.
    Abstract     Related articles   

  333. CHOGHAKHORI R, Abbasnezhad A, Amani R, Alipour M, et al
    Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.
    Dig Dis Sci. 2017 Apr 3. doi: 10.1007/s10620-017-4554.
    Abstract     Related articles   

  334. REZAIE A, Park SC, Morales W, Marsh E, et al
    Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
    Dig Dis Sci. 2017 Apr 27. doi: 10.1007/s10620-017-4585.
    Abstract     Related articles   

  335. KOLOSKI NA, Jones M, Hammer J, von Wulffen M, et al
    The Validity of a New Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS) for Evaluating Symptoms in the Clinical Setting.
    Dig Dis Sci. 2017 May 27. doi: 10.1007/s10620-017-4599.
    Abstract     Related articles   

  336. PIMENTEL M, Cash BD, Lembo A, Wolf RA, et al
    Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity.
    Dig Dis Sci. 2017 Jun 6. doi: 10.1007/s10620-017-4598.
    Abstract     Related articles   

  337. MURAKAMI T, Kamada K, Mizushima K, Higashimura Y, et al
    Changes in Intestinal Motility and Gut Microbiota Composition in a Rat Stress Model.
    Digestion. 2017;95:55-60.
    Abstract     Related articles   

  338. D'ANGELO F, Felley C, Frossard JL
    Calprotectin in Daily Practice: Where Do We Stand in 2017?
    Digestion. 2017;95:293-301.
    Abstract     Related articles   

  339. AL-SALAMA ZT, Syed YY
    Plecanatide: First Global Approval.
    Drugs. 2017 Mar 3. doi: 10.1007/s40265-017-0718.
    Abstract     Related articles   

    Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.
    Drugs. 2017 May 11. doi: 10.1007/s40265-017-0756.
    Abstract     Related articles   

  341. MUJAGIC Z, Jonkers DM, Hungin AP, de Wit NJ, et al
    Use of Rome criteria for the diagnosis of irritable bowel syndrome in primary care: a survey among European countries.
    Eur J Gastroenterol Hepatol. 2017 Jan 25. doi: 10.1097/MEG.0000000000000848.
    Abstract     Related articles   

  342. BALLOU S, Keefer L
    Development of the Irritable Bowel Syndrome Cognitive Affective Scale: a brief self-report measure for clinical and research settings.
    Eur J Gastroenterol Hepatol. 2017 Mar 23. doi: 10.1097/MEG.0000000000000872.
    Abstract     Related articles   

  343. LI ZY, Zhang N, Wen S, Zhang J, et al
    Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome.
    Clin Res Hepatol Gastroenterol. 2017 Feb 16. pii: S2210-7401(17)30006.
    Abstract     Related articles   

  344. RINGEL Y
    The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders.
    Gastroenterol Clin North Am. 2017;46:91-101.
    Abstract     Related articles   

  345. DINAN TG, Cryan JF
    The Microbiome-Gut-Brain Axis in Health and Disease.
    Gastroenterol Clin North Am. 2017;46:77-89.
    Abstract     Related articles   

  346. MURTAZA N, O Cuiv P, Morrison M
    Diet and the Microbiome.
    Gastroenterol Clin North Am. 2017;46:49-60.
    Abstract     Related articles   

  347. KLEM F, Wadhwa A, Prokop L, Sundt W, et al
    Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: a Systematic Review and Meta-analysis.
    Gastroenterology. 2017 Jan 6. pii: S0016-5085(17)30008.
    Abstract     Related articles   

  348. QUIGLEY EM, Lembo AJ
    Irritable Bowel Syndrome: An Infectious Disease?
    Gastroenterology. 2017 Mar 1. pii: S0016-5085(17)30215.
    Abstract     Related articles   

  349. SOOD R, Ford AC
    Derivation and Validation of a Panel of Exhaled Volatile Organic Compounds in Differentiating Irritable Bowel Syndrome From Health.
    Gastroenterology. 2016;151:1245-1246.
    Abstract     Related articles   

  350. DAI C, Jiang M, Sun MJ
    Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Gastroenterology. 2017 Apr 1. pii: S0016-5085(17)30220.
    Abstract     Related articles   

  351. PINTO-SANCHEZ MI, Hall GB, Ghajar K, Nardelli A, et al
    Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: a Pilot Study in Patients With Irritable Bowel Syndrome.
    Gastroenterology. 2017 May 5. pii: S0016-5085(17)35557.
    Abstract     Related articles   

  352. GRACIE DJ, Ford AC
    Irritable bowel syndrome-type symptoms are associated with psychological co-morbidity, reduced quality of life, and healthcare utilization in patients with inflammatory bowel disease.
    Gastroenterology. 2017 May 29. pii: S0016-5085(17)35679.
    Abstract     Related articles   

  353. CAMILLERI M, Sellin JH, Barrett KE
    Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.
    Gastroenterology. 2017;152:515-532.
    Abstract     Related articles   

  354. MARTINEZ C, Rodino-Janeiro BK, Lobo B, Stanifer ML, et al
    miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea.
    Gut. 2017 Jan 12. pii: gutjnl-2016-311477. doi: 10.1136/gutjnl-2016-311477.
    Abstract     Related articles   

  355. ROLLAND-FOURCADE C, Denadai-Souza A, Cirillo C, Lopez C, et al
    Epithelial expression and function of trypsin-3 in irritable bowel syndrome.
    Gut. 2017 Jan 17. pii: gutjnl-2016-312094. doi: 10.1136/gutjnl-2016-312094.
    Abstract     Related articles   

  356. SIMREN M, Tornblom H, Palsson OS, van Tilburg MA, et al
    Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts.
    Gut. 2017 Jan 19. pii: gutjnl-2016-312361. doi: 10.1136/gutjnl-2016-312361.
    Abstract     Related articles   

    Novel insight in diarrhoea-predominant IBS: miRNAs modulate barrier function.
    Gut. 2017 Feb 9. pii: gutjnl-2016-313525. doi: 10.1136/gutjnl-2016-313525.
    Abstract     Related articles   

  358. CAMILLERI M, Boeckxstaens G
    Dietary and pharmacological treatment of abdominal pain in IBS.
    Gut. 2017 Feb 23. pii: gutjnl-2016-313425. doi: 10.1136/gutjnl-2016-313425.
    Abstract     Related articles   

  359. AN S, Zong G, Wang Z, Shi J, et al
    Activation of protease-activated receptor 4 of mast cells could downregulate proinflammatory cytokines in irritable bowel syndrome.
    Gut. 2017 Mar 8. pii: gutjnl-2016-313504. doi: 10.1136/gutjnl-2016-313504.
    Abstract     Related articles   

    Identification of an epithelial member of the protease family, supporting the potential diagnostic and therapeutic role of serine proteases in IBS.
    Gut. 2017 Mar 10. pii: gutjnl-2016-313664. doi: 10.1136/gutjnl-2016-313664.
    Abstract     Related articles   

  361. BENNET SMP, Bohn L, Storsrud S, Liljebo T, et al
    Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
    Gut. 2017 Apr 17. pii: gutjnl-2016-313128. doi: 10.1136/gutjnl-2016-313128.
    Abstract     Related articles   

  362. STAUDACHER HM, Whelan K
    The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS.
    Gut. 2017 Jun 7. pii: gutjnl-2017-313750. doi: 10.1136/gutjnl-2017-313750.
    Abstract     Related articles   

  363. MAVRANGELOS C, Campaniello MA, Andrews JM, Bampton PA, et al
    Longitudinal analysis indicates symptom severity influences immune profile in irritable bowel syndrome.
    Gut. 2017 Jun 10. pii: gutjnl-2017-314308. doi: 10.1136/gutjnl-2017-314308.
    Abstract     Related articles   

  364. DONNACHIE E, Schneider A, Mehring M, Enck P, et al
    Incidence of irritable bowel syndrome and chronic fatigue following GI infection: a population-level study using routinely collected claims data.
    Gut. 2017 Jun 10. pii: gutjnl-2017-313713. doi: 10.1136/gutjnl-2017-313713.
    Abstract     Related articles   

  365. CHOI YJ, Kim N, Yoon H, Shin CM, et al
    Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
    J Gastroenterol Hepatol. 2017 Feb 4. doi: 10.1111/jgh.13756.
    Abstract     Related articles   

  366. GIBSON PR
    Use of the low-FODMAP diet in inflammatory bowel disease.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:40-42.
    Abstract     Related articles   

  367. ANKERSEN DV, Carlsen K, Marker D, Munkholm P, et al
    Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:27-31.
    Abstract     Related articles   

  368. IACOVOU M
    Adapting the low FODMAP diet to special populations: infants and children.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:43-45.
    Abstract     Related articles   

  369. GIBSON PR
    History of the low FODMAP diet.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:5-7.
    Abstract     Related articles   

  370. WILSON B, Whelan K
    Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:64-68.
    Abstract     Related articles   

  371. TAN VP
    The low-FODMAP diet in the management of functional dyspepsia in East and Southeast Asia.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:46-52.
    Abstract     Related articles   

    How to institute the low-FODMAP diet.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:8-10.
    Abstract     Related articles   

  373. GIBSON PR
    The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy?
    J Gastroenterol Hepatol. 2017;32 Suppl 1:32-35.
    Abstract     Related articles   

  374. GIBSON PR, Skodje GI, Lundin KE
    Non-coeliac gluten sensitivity.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:86-89.
    Abstract     Related articles   

  375. HALMOS EP
    When the low FODMAP diet does not work.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:69-72.
    Abstract     Related articles   

  376. VARNEY J, Barrett J, Scarlata K, Catsos P, et al
    FODMAPs: food composition, defining cutoff values and international application.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:53-61.
    Abstract     Related articles   

  377. TUCK C, Barrett J
    Re-challenging FODMAPs: the low FODMAP diet phase two.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:11-15.
    Abstract     Related articles   

  378. O'KEEFFE M, Lomer MC
    Who should deliver the low FODMAP diet and what educational methods are optimal: a review.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:23-26.
    Abstract     Related articles   

  379. MALAKAR S
    Bioactive food chemicals and gastrointestinal symptoms: a focus of salicylates.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:73-77.
    Abstract     Related articles   

  380. MEANCE S, Giordano J, Chuang E, Schneider H, et al
    Food regulations: low FODMAP labeling and communication goals.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:62-63.
    Abstract     Related articles   

    Nutritional, microbiological and psychosocial implications of the low FODMAP diet.
    J Gastroenterol Hepatol. 2017;32 Suppl 1:16-19.
    Abstract     Related articles   

  382. SAHOO S, Padhy SK
    Cross-cultural and Psychological issues in Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2017 Feb 27. doi: 10.1111/jgh.13773.
    Abstract     Related articles   

  383. NOZU T, Miyagishi S, Kumei S, Nozu R, et al
    A glucagon-like peptide-1 analog, liraglutide improves visceral sensation and gut permeability in rats.
    J Gastroenterol Hepatol. 2017 Apr 25. doi: 10.1111/jgh.13808.
    Abstract     Related articles   

  384. QUACH DT, Hiyama T, Nguyen TA, Ly HQ, et al
    The Asia-Pacific Colorectal Screening Score Is Useful To Stratify Risk for Colorectal Advanced Neoplasms in Vietnamese Patients with Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2017 May 11. doi: 10.1111/jgh.13821.
    Abstract     Related articles   

  385. JIN Y, Ren X, Li G, Li Y, et al
    Rifaximin exerts beneficial effects in PI-IBS mouse model beyond gut microbiota.
    J Gastroenterol Hepatol. 2017 Jun 1. doi: 10.1111/jgh.13841.
    Abstract     Related articles   

  386. FYSEKIDIS M, Bouchoucha M, Mary F, Airinei G, et al
    Change of appetite in patients with Functional digestive Disorder. Association with psychological disorders: a cross-sectional study.
    J Gastroenterol Hepatol. 2017 May 27. doi: 10.1111/jgh.13836.
    Abstract     Related articles   

  387. ALI A, Weiss TR, Dutton A, McKee D, et al
    Mindfulness-Based Stress Reduction for Adolescents with Functional Somatic Syndromes: A Pilot Cohort Study.
    J Pediatr. 2017 Jan 12. pii: S0022-3476(16)31548.
    Abstract     Related articles   

  388. GIANNETTI E, Maglione M, Sciorio E, Coppola V, et al
    Do Children Just Grow Out of Irritable Bowel Syndrome?
    J Pediatr. 2017 Jan 18. pii: S0022-3476(16)31435.
    Abstract     Related articles   

  389. BONVANIE IJ, Kallesoe KH, Janssens KAM, Schroder A, et al
    Psychological Interventions for Children with Functional Somatic Symptoms: A Systematic Review and Meta-Analysis.
    J Pediatr. 2017 Apr 14. pii: S0022-3476(17)30366.
    Abstract     Related articles   

  390. SCARPATO E, Quitadamo P, Roman E, Jojkic-Pavkov D, et al
    Functional Gastrointestinal Disorders in Children: A Survey on Clinical Approach in the Mediterranean Area.
    J Pediatr Gastroenterol Nutr. 2017;64:e142-e146.
    Abstract     Related articles   

  391. NORLIN AK, Walter S, Theodorsson E, Tegelstrom V, et al
    Cortisol levels in hair are altered in irritable bowel syndrome - A case control study in primary care.
    J Psychosom Res. 2017;93:69-75.
    Abstract     Related articles   

  392. LEE SK, Yoon DW, Lee S, Kim J, et al
    The association between irritable bowel syndrome and the coexistence of depression and insomnia.
    J Psychosom Res. 2017;93:1-5.
    Abstract     Related articles   

  393. EL-SALHY M, Patcharatrakul T, Hatlebakk JG, Hausken T, et al
    Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome.
    Scand J Gastroenterol. 2017 Mar 27:1-7. doi: 10.1080/00365521.2017.1305123.
    Abstract     Related articles   

  394. NWOSU BU, Maranda L, Candela N
    Vitamin D status in pediatric irritable bowel syndrome.
    PLoS One. 2017;12:e0172183.
    Abstract     Related articles   

  395. KUO B, Bhasin M, Jacquart J, Scult MA, et al
    Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease.
    PLoS One. 2017;12:e0172872.
    Abstract     Related articles   

  396. NWOSU BU, Maranda L, Candela N
    Correction: Vitamin D status in pediatric irritable bowel syndrome.
    PLoS One. 2017;12:e0173779.
    Abstract     Related articles   

  397. ZHENG Y, Yu T, Tang Y, Xiong W, et al
    Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2017;12:e0172846.
    Abstract     Related articles   

  398. KATO T, Honda Y, Kurita Y, Iwasaki A, et al
    Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.
    PLoS One. 2017;12:e0175626.
    Abstract     Related articles   

  399. SHARMAN SK, Islam BN, Hou Y, Usry M, et al
    Sildenafil normalizes bowel transit in preclinical models of constipation.
    PLoS One. 2017;12:e0176673.
    Abstract     Related articles   

  400. WANG W, Xin H, Fang X, Dou H, et al
    Isomalto-oligosaccharides ameliorate visceral hyperalgesia with repair damage of ileal epithelial ultrastructure in rats.
    PLoS One. 2017;12:e0175276.
    Abstract     Related articles   

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.